ANDA 80452, held by Everylife. Hydrocortisone.
As of Nov 13, 2026, ANDA 80452 (Hydrocortisone), held by Everylife, was not approved, with 0 approved supplements and 0 published complete response letters.
| Hydrocortisone0.5% · cream;topical | Hydrocortisone | Discontinued |
| Hydrocortisone1% · cream;topical | Hydrocortisone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters